Eli Lilly and Company (LLY) Earnings

Eli Lilly and Company

LLY · NYSE

Symbol: LLY
Type: Stock
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Country: North America
Exchange: NYSE

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people.

Key Issues

Bullish view

Strong demand for Lilly’s GLP-1 drugs is driving rapid revenue growth, and the company cited continued strength in key products when raising its full-year revenue outlook.

Bearish view

The Motley Fool’s discussion of whether the stock is running out of steam highlights the risk that investor expectations and the GLP-1 growth narrative may already be too demanding.

Analyst Consensus

See all

Buy

23 analysts

$1,165

Current

—

Low

$1,300

Average

—

High

Average target implies +11.54% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Johnson & JohnsonJNJ · NYSE

Eli Lilly and Company

Next quarter

LLY Mar 2026